Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 2/20 | 0.61 |
| ▸ | DRD2 | P14416 | 4/20 | 0.55 |
| ▸ | DRD1 | P21728 | 4/20 | 0.55 |
| ▸ | DRD5 | P21918 | 4/20 | 0.55 |
| ▸ | DRD3 | P35462 | 4/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 1/20 | 0.51 |
| ▸ | CA6 | P23280 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HTR2A | P28223 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822754 | 0.90 | MEN1 (0.54) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL3287680 | 0.90 | ALDH1A1 (0.56) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL4581239 | 0.86 | METAP1 (0.63) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL30777630 | 0.86 | METAP1 (0.63) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL11649220 | 0.85 | MAOA (0.51) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL6907774 | 0.83 | DRD1 (0.68) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL12595448 | 0.83 | — | — | |
| SCHEMBL6903663 | 0.83 | DRD1 (0.68) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL29633762 | 0.81 | DRD1 (0.58) | METAP1DRD2DRD1DRD5DRD3 | |
| SCHEMBL2914928 | 0.81 | DRD1 (0.58) | METAP1DRD2DRD1DRD5DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5169830-A | — | — | None | — | — | JP | disclosed |
| US-20160334705-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | KODAK REALTY INC. | 2016-11-17 | — | — | US | disclosed |
| US-8084559-B2 | Ethylene-vinylcyclohexane copolymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2008-07-03 | — | — | US | disclosed |
| JP-H05169830-A | THERMAL RECORDING MATERIAL | KANZAKI PAPER MFG CO LTD | 1993-07-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | AOC2, ACSL1, ACSL3 | METAP1 2844/4885DRD2 2423/4885DRD1 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.